Medexus Pharmaceuticals Inc. (MEDXF)
OTC Markets OTCQX - OTC Markets OTCQX Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 2.0000 |
| Open | 2.0000 |
| Bid | 1.5300 x 40000 |
| Ask | 2.0000 x 40000 |
| Day's Range | 2.0000 - 2.0000 |
| 52 Week Range | 1.0600 - 2.5620 |
| Volume | |
| Avg. Volume | 11,909 |
| Market Cap | 48.928M |
| Beta (5Y Monthly) | 1.95 |
| PE Ratio (TTM) | 49.88 |
| EPS (TTM) | 0.0400 |
| Earnings Date | Aug 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Some May Be Optimistic About Medexus Pharmaceuticals' (TSE:MDP) Earnings
Medexus Pharmaceuticals Inc.'s ( TSE:MDP ) stock was strong despite it releasing a soft earnings report last week. We...
- Simply Wall St.
Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Medexus Pharmaceuticals Inc. ( TSE:MDP ) just released its first-quarter report and things are looking bullish. It was...
NewsfileMedexus Announces Strong Fiscal Q1 2025 Results
Fiscal Q1 2025 revenue of $27.3 million, net income of $2.0 million, operating income of $4.0 million, and Adjusted EBITDA* of $6.1 millionManagement to host conference call at 8:00 AM Eastern time on Thursday, August 8, 2024Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 7, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company's first fiscal quarter ended June 30, ...
© 2024 Yahoo. All rights reserved.